Literature DB >> 3722423

Quality control of oestrogen receptor assays using frozen breast tumours.

S Y Wong, G King, B Angus, A Tesdale, R A Hawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3722423      PMCID： PMC500000          DOI： 10.1136/jcp.39.6.690-b

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  7 in total

1.  Radio-ligand binding assay of specific estrogens using a soluble uterine macromolecule.

Authors:  S G Korenman
Journal:  J Clin Endocrinol Metab       Date:  1968-01       Impact factor: 5.958

2.  Reliability of steroid hormone receptor assays: an international study.

Authors:  V C Jordan; D T Zava; U Eppenburger; A Kiser; S Sebek; E Dowdle; Z Krozowski; R C Bennett; J Funder; I M Holdaway; J L Wittliff
Journal:  Eur J Cancer Clin Oncol       Date:  1983-03

3.  British interlaboratory quality assessment of steroid receptor assays.

Authors:  S Cowan; R E Leake
Journal:  Recent Results Cancer Res       Date:  1984

4.  Hormone receptors: their role in predicting prognosis and response to endocrine therapy.

Authors:  W L McGuire
Journal:  Semin Oncol       Date:  1978-12       Impact factor: 4.929

5.  Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.

Authors:  J C van der Linden; J P Baak; T Postma; J Lindeman; C J Meyer
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

6.  Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors:  R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

7.  Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.

Authors:  J R Sainsbury; A J Malcolm; D R Appleton; J R Farndon; A L Harris
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.